Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Presentation Title: Personalized and Precision Medicine (PPM) through the Lens of Biodesign-Inspired Translational Research
Excited to share insights on how genomics-informed care is reshaping the future of oncology.
From NGS and GWAS technologies to biopredictors of pre-cancer conditions, the era of Personalized & Precision Oncology (PPO) is enabling us to detect, classify, and treat cancer at an unprecedented level of accuracy.
Key highlights:
✨ Subclinical recognition of genomic abnormalities long before symptoms emerge
✨ Identification of actionable mutations for targeted therapy
✨ Integrating genomics-driven data to improve outcomes and reduce adverse events
✨ Biodesign as a driving force for next-generation diagnostic and therapeutic tools
✨ The need for clear clinical guidelines to accelerate PPM adoption
The future of cancer care lies in collaboration between clinicians, pathologists, bioengineers, and biodesign experts—working together to transform treatment pathways and patient safety.
